Table 3.
Univariate and multivariate survival analysis of ACC patients for cancer-specific survival.
| Characteristic | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| Age (yr) | 1.010 | 1.002–1.018 | .017 | |||
| Sex | ||||||
| Male | Reference | |||||
| Female | 0.907 | 0.802–1.026 | .907 | |||
| Marital status | ||||||
| Married | Reference | |||||
| Unknown/Unmarried | 0.981 | 0.867–1.110 | .762 | |||
| Median income | ||||||
| <$7500 | Reference | |||||
| ≥$75,000 | 1.007 | 0.884–1.147 | .918 | |||
| Race | ||||||
| White | Reference | |||||
| Black | 0.745 | 0.520–1.065 | .107 | |||
| Others | 1.185 | 0.855–1.642 | .308 | |||
| Laterality | ||||||
| Left | Reference | |||||
| Right | 0.930 | 0.824–1.050 | .243 | |||
| T stage | ||||||
| pT1–2 | Reference | Reference | ||||
| pT3–4 | 2.330 | 1.816–2.990 | <.001 | 2.060 | 1.589–2.671 | <.001 |
| N stage | ||||||
| pN0 | Reference | |||||
| pN1 | 2.728 | 1.933–3.850 | <.001 | |||
| Surgery performed | ||||||
| Yes | Reference | Reference | ||||
| No | 2.341 | 2.032–2.696 | <.001 | 3.944 | 2.885–5.390 | <.001 |
| Radiation | ||||||
| Yes | Reference | |||||
| No | 1.151 | 0.983–1.348 | .081 | 1.507 | 1.075–2.114 | .017 |
| Chemotherapy | ||||||
| Yes | Reference | |||||
| No | 0.822 | 0.727–0.929 | .002 | |||
| Bone metastases | ||||||
| Yes | Reference | Reference | ||||
| No | 0.615 | 0.489–0.773 | <.001 | 0.427 | 0.259–0.704 | .001 |
| Liver metastases | ||||||
| Yes | Reference | Reference | ||||
| No | 0.458 | 0.394–0.533 | <.001 | 0.525 | 0.372–0.740 | <.001 |
| Lung metastases | ||||||
| Yes | Reference | |||||
| No | 0.551 | 0.481–0.633 | <.001 | |||
ACC = adrenocortical carcinoma, CI = confidence interval, HR = hazard ratio.